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Background. Consensus national guidelines (2011) recommend narrow-spectrum
penicillins (penicillin, ampicillin, amoxicillin) for children hospitalized with uncom-
plicated pneumonia. Prior to guideline release, most hospitalized children received sec-
ond/third generation cephalosporins. We assessed the impact of the national guideline
and subsequent hospital-level interventions on antibiotic choice across a national
sample.
Methods. We identified children 6 months to 18 years from 28 children’s hospitals
admitted between August 2009 and March 2015 with a diagnosis of pneumonia and
who received antibiotics within the first 2 hospital days. Each hospital was surveyed
regarding local activities implemented after guideline release (e.g. clinical practice
guideline [CPG]). Outcomes included the monthly percentage of children receiving
penicillins or cephalosporins. Interrupted time series analysis was used to assess the
national guideline impact by comparing the absolute change in prescribing at the
end of the study ([observed % from post-guideline trend] – [expected % from pre-
guideline trend]) aggregated across all hospitals. Hospital-level analyses assessed the
impact of local activities.
Results. A total of 58,559 pneumonia hospitalizations were included. Prior to the
national guideline, penicillin use was rare (<10%); cephalosporins accounted for ∼60%
of prescribing. After guideline release, 19 hospitals (68%) implemented a new CPG and
20 (71%) implemented a new order set. By the end of the study and compared with
pre-guideline trends, we noted an absolute increase in penicillin use of 27.6% (95% CI:
23.7%–31.5%) [Figure 1]. Cephalosporin use declined by a similar magnitude (not
shown). Prescribing changes varied across hospitals [Figure 2]. Among hospitals im-
plementing a CPG or order set, the median difference was 29.5 [IQR 19.6, 39.1] for
penicillins, while among hospitals without local activities, the median difference was
20.1 [9.5, 44.5]; these differences were not statistically significant.
Conclusion. Antibiotic prescribing for pneumonia changed substantially after re-
lease of a national guideline, although institutional adoption varied. Local implemen-
tation efforts may enhance appropriate antibiotic selection, but room for improvement
remains.
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